Summary
To test a method of assessing quality of life, 200 primary brain tumor patients in an outpatient clinic answered a 20-minute questionnaire covering ten aspects of quality of life. These results were compared with Karnofsky performance scale (KPS) scores, taking age into account. Among patients with KPS 90–100 (two-thirds of the patients), the KPS alone was difficult to interpret. The questionnaire, with its specific questions related to the key dimension of well-being, provided a more definitive assessment of status. The central importance of well-being was supported by its strong statistical relationships with other dimensions. Particularly, well-being was related to freedom from depression (p < 0.0001), active social life (p < 0.0001), energy (p < 0.01), and fewer symptoms (p < 0.05). The KPS was more useful in differentiating the other one-third of the patients (KPS 50–80) but was highly sensitive to age. KPS scores, therefore, may have been unreliable. Depression, reported by half of the patients, was not predicted by the KPS when age was excluded from the regression analysis but was related to the scores in well-being and socializing. Neither depression, well-being, nor socializing was influenced by age. Thus, the questionnaire directly assessed these central, emotionally based variables, particularly among patients with satisfactory KPS. Such an assessment is especially crucial as a supplement to the KPS in evaluating brain tumor survivors, whose emotional well-being is often severely challenged by treatment after surgical excision.
Similar content being viewed by others
References
Campbell A: Subjective measures of well being. Am Psychol 31: 117–124, 1976
Maslow AH: A theory of human motivation. Psychol Rev 50: 370–396, 1943
Maslow AH: The Farther Reaches of Human Nature. Penguin Books, New York 42–43, 1976
Donovan K, Sanson-Fisher RW, Redman S: Measuring quality of life in cancer patients. J Clin Oncol 7: 959–968, 1989
DeHaes JCJM, Van Kippenberg FCE: The quality of life of cancer patients: A review of the literature. Soc Sci Med 20: 809–817, 1985
Duncan W: Caring of curing: Conflicts of choice. J R Soc Med 78: 526–536, 1985
Mullan F: Seasons of survival: Reflections of a physician with cancer. N Engl J Med 313: 270–273, 1985
Najman JM, Levine S: Evaluating the impact of medical care and technologies on the quality of life: A review and critique. Soc Sci Med 15F: 107–115, 1981
Silberfarb PM; Psychiatric problems in breast cancer. Cancer 53: 820–824, 1984
Stehlin JS, Bach KN: Psychological aspects of cancer therapy. JAMA 197: 140–144, 1986
Weisman AD, Worden JW: The existential plight in cancer: Significance of the first 100 days. Int J Psychiatry Med 7: 1–15, 1976–1977
Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH: The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1: 634–656, 1948
Karnofsky DA, Burchenal JH: The clinical evaluation of chemotherapeutic agents in cancer. In: Macleod CM (ed) Evaluation of Chemotherapeutic Agents. Columbia University Press, New York 199–205, 1949
Aisner J, Hansen HH; Commentary: Current status of chemotherapy for non-small cell lung cancer. Cancer Rep 65: 979–986, 1981
Tannock I, Murphy K: Reflections on medical oncology: An appeal for better clinical trials and improved reporting of their results. J Clin Oncol 1: 66–70, 1983
Stanley KE: Prognostic factors for survival in patients with inoperable lung cancer. J Natl Cancer Inst 65: 25–32, 1980
Berry WR, Laszlo J, Cox E, Walker A, Paulson D: Prognostic factors in metastatic and hormonally unresponsive carcinoma of the prostate. Cancer 44: 763–775, 1979
Schag CC, Heinrich RL, Ganz PA: Karnofsky performance scale revisited: Reliability, validity, and guidelines. J Clin Oncol 2: 187–193, 1984
Buchanan RB, Blarney RW, Durrant KR, Howell A, Paterson AG, Preece PE, Smith DC, Williams CJ, Wilson RG: A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer. J Clin Oncol 4: 1326–1330, 1986
Trojanowski T, Peszynski J, Turowski K, Kaminski S, Goscinski I, Reinfus M, Krzyszkowski T, Pyrich M, Bielawski A, Leszczyk C, Bendarzewska B, Staszczak A, Kozniewska H: Postoperative radiotherapy and radiotherapy combined with CCNU chemotherapy for treatment of brain gliomas. J Neuro-Oncol 6: 285–291, 1988
LeBaron S, Zeltzer PM, Zeltzer LK, Scott SE, Marlin AE: Assessment of quality of survival in children with medulloblastoma and cerebellar astrocytoma. Cancer 62: 1215–1222, 1988
Packer RJ, Sutton LN, Atkins TE, Radcliffe J, Bunin GR, D'Angio G, Siegel KR, Schut L: A prospective study of cognitive function in children receiving whole-brain radiotherapy and chemotherapy: 2-year results. J Neurosurg 70: 707–713, 1989
Cella DF, Tulsky DS: Measuring quality of life today: Methodological aspects. Oncology 4: 29–38, 1990
Aaronson NK, Bakker W, Stewart AL, Van Dam FSAM, van Zandwijk S, Yarnold JL, Kirkpatrick A: Multidimensional approach to the measurement of quality of life in lung cancer clinical trials. In: Aaronson NK, Beckmann JH (eds) The Quality of Life of Cancer Patients. Raven Press, New York 63–82, 1987
Levine MN, Guyatt GH, Gent M: Quality of life in stage II breast cancer: An instrument for clinical trials. J Clin Oncol 6: 1798–1810, 1988
Fobair P, Hoppe RT, Bloom J, Cox R, Varghese A, Spiegel D: Psychosocial problems among survivors of Hodgkin's disease. J Clin Oncol 4: 805–814, 1986
Wilson B, Cockburn J, Baddeley A, Hiorns R: The development and validation of a test battery for detecting and monitoring everyday memory problems. J Clin Exp Neuropsychol 11: 855–870, 1989
Yates JW, Chalmer B, McKegney FP: Evaluation of patients with advanced cancer using the Karnofsky Performance Status. Cancer 45: 2220–2224, 1980
Jacobsen PB, Andrykowski MA, Redd WH, Die-Trill M, Hakes TB, Kaufman RJ, Currie VE, Holland JC: Nonpharmacologic factors in the development of post-treatment nausea with adjuvant chemotherapy for breast cancer. Cancer 61: 379–385, 1988
Peck A, Boland J: Emotional reactions to radiation treatment. Cancer 40: 180–184, 1977
Wells KB, Hays RD, Burnam A, Rogers W, Greenfield S, Ware JE Jr: Detection of depressive disorder for patients receiving prepaid or fee-for-service care. Results from the Medical Outcomes Study. JAMA 262: 3298–3302, 1989
Pelletier KR, Herzing DL: Psychoneuroimmunology: Toward a mindbody model. Advances 5: 27–56, 1989
Fawzy FI, Kemeny ME, Fawzy NW, Elashoff R, Morton D, Cousins N, Fahey JL: A structured psychiatric intervention for cancer patients. II. Changes over time in immunological measures. Arch Gen Psychiatry 47: 729–735, 1990
Angell M: Disease as a reflection of the psyche. N Engl J Med 312: 373–375, 1985
Cassileth BR, Lusk EJ, Miller DS, Brown LL, Miller C: Psychosocial correlates of survival in advanced malignant disease? N Engl J Med 312: 1551–1555, 1985
Calabrese JR, Kling MA, Gold PW: Alterations in immunocompetence during stress, bereavement and depression: Focus on neuroendocrine regulation. Am J Psychiatry 144: 1123–1134, 1987
Levy SM, Herberman RB, Lippman M: Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer. J Clin Oncol 5: 348–353, 1987
Levy SM, Herberman RB, Maluish AM, Schlien B, Lippman M: Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters. Health Psychol 4: 99–113, 1985
Solomon GF: Psychoneuroimmunology: Interactions between central nervous system and immune system. J Neurosci Res 18: 1–9, 1987
Fawzy FI, Cousins N, Fawzy NW, Kemeny ME, Elashoff R, Morton D: A structured psychiatric intervention for cancer patients. I. Changes over time in methods of coping and affective disturbance. Arch Gen Psychiatry 47: 720–725, 1990
Temoshok L: Biopsychosocial studies on cutaneous malignant melanoma: Psychological factors associated with prognostic indicators, progression, psychophysiology and tumor-host response. Soc Sci Med 20: 833–840, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mackworth, N., Fobair, P. & Prados, M.D. Quality of life self-reports from 200 brain tumor patients: comparisons with Karnofsky performance scores. J Neuro-Oncol 14, 243–253 (1992). https://doi.org/10.1007/BF00172600
Issue Date:
DOI: https://doi.org/10.1007/BF00172600